Rafaella Navarro

Rafaella Navarro

Auto-generated profile, based on publicly available information

Rafaella Navarro

Instituto de Medicina Tropical Alexander von Humboldt, Universidad Peruana Cayetano Heredia

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 December 2022 in BioMetals
Verified
Journal Article
Open access
PDF file
RNRafaella Navarro
Rafaella Navarro
JPJose Luis Paredes
Jose Luis Paredes
LTLourdes Tucto
Lourdes Tucto
CMCarlos Medina
Carlos Medina
EAEddie Angles-Yanqui
Eddie Angles-Yanqui
TOTheresa Jean Ochoa
Theresa Jean Ochoa
Lactoferrin (LF) has in vitro antiviral activity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This study aimed to determine the effect of bovine lactoferrin (bLF) in the prevention of SARS-CoV-2 infection in health care personnel. A randomized, double-blinded, placebo-controlled clinical trial was conducted in two tertiary hospitals that provide care to patients with SARS-CoV-2 infection in Lima, Peru. Daily supplementation with 600 mg of enteral bLF versus placebo for 90 days was compared. Participants were weekly screened for symptoms suggestive of SARS-CoV-2 infection and molecular testing was performed on suspected episodes. A serological test was obtained from all participants at the end of the intervention. The main outcome included symptomatic and asymptomatic cases. A sub-analysis explored the time to symptomatic infection. Secondary outcomes were the severity, frequency, and duration of symptomatic infection. The study was prematurely cancelled due to the availability of vaccines against SARS-CoV-2 in Peru. 209 participants were enrolled and randomized, 104 received bLF and 105 placebo. SARS-CoV-2 infection occurred in 11 (10.6%) participants assigned to bLF and in 9 (8.6%) participants assigned to placebo without significant differences (Incidence Rate Ratio = 1.23, 95%CI 0.51–3.06, p-value = 0.64). There was no significant effect of bLF on time to symptomatic infection (Hazard Ratio = 1.61, 95%CI 0.62–4.19, p-value = 0.3). There were no significant differences in secondary outcomes. A significant effect of bLF in preventing SARS-CoV-2 infection was not proven. Further studies are needed to assess the effect of bLF supplementation on SARS-CoV-2 infection. Clinical trial registration ClinicalTrials.gov Identifier: NCT04526821, https://clinicaltrials.gov/ct2/show/NCT04526821?term=LACTOFERRIN&cond=COVID-19&cntry=PE&city=Lima&draw=2&rank=1.

19 August 2021 in PLOS ONE
Verified
Journal Article
Open access
PDF file
RNRafaella Navarro
Rafaella Navarro
JPJose Luis Paredes
Jose Luis Paredes
JEJuan Echevarría
Juan Echevarría
EGElsa González-Lagos
Elsa González-Lagos
AGAna Graña
Ana Graña
LOLarissa Otero
Larissa Otero
This study aims to describe knowledge on HIV and antiretroviral (ARV) treatment and psychosocial factors among people living with HIV (PLWH) in Lima, Perú, to explore characteristics associated to this knowledge, and determine its impact on sustained viral suppression. A cross-sectional survey was conducted among 171 PLWH at the largest referral health care center in Lima. The psychosocial factors measured were depression, risk of alcoholism, use of illegal drugs and disclosure. A participant had “poor knowledge” when less than 80% of replies were correct. Sustained viral suppression was defined as two consecutive viral loads under 50 copies/mL. A total of 49% and 43% had poor HIV and ARV knowledge respectively; 48% of the study population screened positive for depression and 27% reported feeling unsupported by the person they disclosed to. The largest gaps in HIV and ARV knowledge were among 98 (57%) that did not recognize that HIV increased the risk of cancer and among 57 (33%) participants that did not disagree with the statement that taking a double dose of ARV if they missed one. Moderate depression was significantly associated to poor HIV and ARV knowledge. Non-disclosure and being on ARVs for less than 6 months were associated with not achieving sustained viral suppression. Our findings highlight important HIV and ARV knowledge gaps of PLWH and a high burden of psychosocial problems, especially of depression, among PLWH in Lima, Peru. Increasing knowledge and addressing depression and disclosure could improve care of PLWH.

21 March 2022 in Revista Peruana de Medicina Experimental Y Salud Pública
Verified
Journal Article
Open access
PDF file
JPJose Luis Paredes
Jose Luis Paredes
RNRafaella Navarro
Rafaella Navarro
JAJorge Luis Andrade-Piedra
Jorge Luis Andrade-Piedra
NHNoemí Hinostroza
Noemí Hinostroza
JEJuan Echevarría
Juan Echevarría
CWCamille Webb
Camille Webb
Se realizó un estudio transversal en estudiantes de Medicina de una universidad privada de Lima. El objetivo fue describir el nivel de conocimientos y las actitudes sobre la COVID-19, además de su percepción sobre el rol de los medios de comunicación y de las redes sociales. El 32% no sabía que en los primeros cinco días de la enfermedad, las pruebas serológicas son preferibles para diagnosticar la COVID-19, comparadas con las pruebas moleculares; el 73% reportó estar dispuesto a trabajar como voluntario durante la pandemia y el 94% recibió información falsa sobre la COVID-19 en las redes sociales. Este estudio demuestra que la información sobre el uso de pruebas diagnósticas debe ser reforzada y que se debe tomar en cuenta el alto porcentaje de estudiantes dispuestos a ser voluntarios durante la pandemia de la COVID-19.

6 July 2022 in Revista Peruana de Medicina Experimental Y Salud Pública
Verified
Journal Article
Open access
PDF file
JPJose Luis Paredes
Jose Luis Paredes
RNRafaella Navarro
Rafaella Navarro
JAJorge Luis Andrade-Piedra
Jorge Luis Andrade-Piedra
NHNoemí Hinostroza
Noemí Hinostroza
JEJuan Echevarría
Juan Echevarría
CWCamille Webb
Camille Webb
Réplica a: precisiones sobre el artículo «Conocimientos, actitudes y percepción sobre el rol de los medios de comunicación respecto a la COVID-19 en estudiantes de medicina de una universidad peruana»

1 January 2026 in Biochemistry and Cell Biology
Verified
Journal Article
Closed access
VRVictor D. Torres Roldan
Victor D. Torres Roldan
VMValerie S. Mayorga
Valerie S. Mayorga
RNRafaella Navarro
Rafaella Navarro
MUMeritxell Urtecho
Meritxell Urtecho
TOTheresa J. Ochoa
Theresa J. Ochoa

25 September 2026 in Revista Peruana de Medicina Experimental Y Salud Pública
Verified
Journal Article
Open access
EREdison A. Rivera-Fernandez
Edison A. Rivera-Fernandez
DDDavid Durand
David Durand
RNRafaella Navarro
Rafaella Navarro
YRYamile Rodriguez-Angeles
Yamile Rodriguez-Angeles
PPPia S. Pannaraj
Pia S. Pannaraj
TOTheresa J. Ochoa
Theresa J. Ochoa
Lactoferrin (LF) is a glycoprotein with antimicrobial and immunomodulatory properties that is present in human milk and plays a fundamental role in infant protection. The objective was to describe LF concentration during the first postpartum year in Northern Lima, Peru. A retrospective observational study was conducted based on a secondary analysis of 158 human milk samples from 83 mothers: 39 transition milk samples (7–14 days) and 119 mature milk samples (2–12 months). LF was quantified using ELISA. The median LF concentration in transition milk was 6.52 (IQR: 5.16–8.15) mg/mL and in mature milk was 1.01 (IQR: 0.80–1.57) mg/mL. During the mature milk periods, the values were 3.33 mg/mL (2 months), 3.27 mg/mL (3–5 months), 2.56 mg/mL (6–7 months), and 2.08 mg/mL (8–12 months). Among the 22 mothers with paired samples, the mean concentration was 7.71 ± 2.27 mg/mL in transition milk and 3.76 ± 1.06 mg/mL at 2 months. The lack of sufficient colostrum samples and the uneven availability of samples limit the complete characterization of the trajectory during the first year. The results describe a decreasing pattern in LF concentration throughout the first year of lactation.